About Arkgen Pharma Private Limited
Data last updated:
Arkgen Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2014PTC075574. Its GSTIN is 29AAMCA7931M1ZZ (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹51 Lakh and a paid-up capital of ₹51 Lakh. It is led by directors including Padiyath Mohammed Akbarali and Hathika Akbarali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.92 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.26 Cr (net margin 19.2%) and EBITDA of ₹4.62 Cr (EBITDA margin 27.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 20% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: ArkGen Pharma. As per MCA filings, the company has open charges of ₹2.8 Cr on record. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2017. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Rangodadhi Chemicals Private Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arkgenpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address306 Vitc Export Bhavana Plot No. 488B 1st Cross 4th Phase Peenya Industrial, Area, Bangalore, Karnataka, India – 560058
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arkgen Pharma Private Limited
The main business activity of Arkgen Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arkgen Pharma Private Limited FY 2025 filings available
Arkgen Pharma Private Limited reported revenue of ₹16.92 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Arkgen Pharma Private Limited
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arkgen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.62 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arkgen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 19.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arkgen Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Arkgen Pharma Private Limited
Arkgen Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rangodadhi Chemicals Private Limited | •••• | •••• | •••• | •••• | 14 | Ahmedabad, Gujarat, India |
| Three A Chemie Private Limited | •••• | •••• | •••• | •••• | - | |
| Hermes Laboratories Private Limited | •••• | •••• | •••• | •••• | 48 | Doddaballapur., Karnataka, India |
| Zefe Labs (I) Private Limited | •••• | •••• | •••• | •••• | - | Indore, Madhya Pradesh, India |
| Cropel Lifesciences Private Limited | •••• | •••• | •••• | •••• | - | Kalol, Gujarat, India |
| Arkgen Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| MNR Labs Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Susaah Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Secunderabad, Telangana, India |
| Sai Sreyas Pharmaceutical Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Rchem Organics (Bangalore) Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Solana Life Sciences Private Limited | •••• | •••• | •••• | •••• | 27 | Dhar, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Arkgen Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Arkgen Pharma Private Limited
Auditor information for Arkgen Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Arkgen Pharma Private Limited
Arkgen Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padiyath Mohammed Akbarali Also directs: Arkgen Enterprises Private Limited | Director | 30 Jul 2014 | 12 Years 2 Months | Current |
| Hathika Akbarali Also directs: Arkgen Enterprises Private Limited | Director | 19 May 2016 | 10 Years 4 Months | Current |
| Amal Amina Akberali Padiyath | Director | 26 Aug 2021 | 5 Years 1 Months | Current |
Ownership and Shareholding of Arkgen Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arkgen Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2019 | Others | ₹1.8 Cr | Open |
| 15 Mar 2016 | State Bank of India | ₹1 Cr | Open |
Total charge records: 2 View all charges
Deals & Funding of Arkgen Pharma Private Limited
Arkgen Pharma Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2017.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: Arkgen Enterprises Private Limited , 2 individuals Seller: an individual |
| Mar 2015 | Rights issue | ₹50 Lakh | Investors: 2 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Arkgen Pharma Private Limited
Arkgen Pharma operates one associated brand: ArkGen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical APIs, intermediates, and provides technical services. | arkgenpharma.com |
Employees and EPFO Compliance at Arkgen Pharma Private Limited
Arkgen Pharma Private Limited has a workforce of 17 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Arkgen Pharma Private Limited
Arkgen Pharma Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Amal Amina Akberali Padiyath was appointed as Director on 26 Aug 2021.
Credit Ratings, Litigation & Regulatory Alerts for Arkgen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arkgen Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arkgen Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arkgen Pharma Private Limited
Arkgen Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAMCA7931M1ZZ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arkgen Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arkgen Pharma Private Limited
Arkgen Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 30 July 2014 (12+ years old) and is registered under CIN U74900KA2014PTC075574.
Arkgen Pharma reported revenue of ₹16.92 Cr for FY 2025 (down 3% YoY).
Arkgen Pharma has 3 current directors:
- Padiyath Mohammed Akbarali - Director
- Hathika Akbarali - Director
- Amal Amina Akberali Padiyath - Director
Arkgen Pharma reported a net profit of ₹3.26 Cr (net margin 19.2%) and EBITDA of ₹4.62 Cr (EBITDA margin 27.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arkgen Pharma is 12% over three years and 20% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arkgen Pharma is 29AAMCA7931M1ZZ, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Arkgen Pharma is U74900KA2014PTC075574. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arkgen Pharma was incorporated on 30 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Arkgen Pharma has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2017.
The peers of Arkgen Pharma by revenue are Rangodadhi Chemicals Private Limited, Three A Chemie Private Limited, Hermes Laboratories Private Limited, Zefe Labs (I) Private Limited, Cropel Lifesciences Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Amal Amina Akberali Padiyath was appointed as Director on 26 Aug 2021. Koodli Venkataramana Udupa ceased to be Director on 26 Aug 2021. Narsi Reddy Poreddy ceased to be Director on 22 Nov 2018. Arkgen Pharma has 6 board changes on record in total.